Free Trial
→ SpaceX eyes a 1.75 trillion valuation - here's what to know (From Brownstone Research) (Ad)tc pixel Free BOLT Stock Alerts

Bolt Biotherapeutics (BOLT) Institutional Ownership

Bolt Biotherapeutics logo
$5.28 -0.02 (-0.38%)
As of 03:23 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Bolt Biotherapeutics (NASDAQ:BOLT)

Current
Institutional Ownership
Percentage
86.70%
Number of
Institutional Buyers
(last 12 months)
6
Total
Institutional Inflows
(last 12 months)
$740.55K
Number of
Institutional Sellers
(last 12 months)
6
Total
Institutional Outflows
(last 12 months)
$50.80M
Get BOLT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Bolt Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

BOLT Institutional Buying and Selling by Quarter

Bolt Biotherapeutics Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/14/2026 Renaissance Technologies LLC77,225$312K0.0%+40.3%4.022%
2/13/2026 Vivo Capital LLC72,414$396K0.0%-58.9%3.772%
2/12/2026 Renaissance Technologies LLC55,025$301K0.0%+92.2%2.866%
2/11/2026 T3 Companies LLC38,000$208K0.3%N/A1.979%
2/6/2026 Nano Cap New Millennium Growth Fund L P20,500$112K0.1%N/A1.068%
11/17/2025 Susquehanna International Group LLP16,642$89K0.0%N/A0.867%
11/14/2025 Shay Capital LLC15,958$85K0.0%N/A0.831%
11/14/2025 Squarepoint Ops LLC14,836$79K0.0%+19.8%0.773%
8/15/2025 Sofinnova Investments Inc.137,721$795K0.0%-95.0%7.173%
8/14/2025 Vivo Capital LLC176,064$986K0.1%-95.0%9.170%
8/14/2025 Nan Fung Group Holdings Ltd58,347$337K0.5%-95.0%3.039%
8/11/2025 Pfizer Inc31,305$181K0.0%-95.0%1.630%
8/8/2025 Geode Capital Management LLC18,533$108K0.0%-95.1%0.965%
7/31/2025 Board of Trustees of The Leland Stanford Junior University35,978$208K0.0%-95.0%1.874%
2/17/2025Velan Capital Investment Management LP50,000$27K0.0%N/A0.131%
2/17/2025Squarepoint Ops LLC48,971$26K0.0%N/A0.128%
2/17/2025Millennium Management LLC47,025$25K0.0%N/A0.123%
2/17/2025Citadel Advisors LLC78,961$42K0.0%N/A0.206%
11/16/2024Geode Capital Management LLC352,426$228K0.0%-5.0%0.921%
11/13/2024FMR LLC115,386$75K0.0%+33.2%0.302%
8/9/2024Renaissance Technologies LLC276,739$208K0.0%-46.5%0.726%
8/5/2024Acuitas Investments LLC630,507$473K0.3%+21.7%1.654%
7/18/2024Assenagon Asset Management S.A.34,488$26K0.0%N/A0.090%
2/15/2024Board of Trustees of The Leland Stanford Junior University719,546$806K0.1%-5.0%1.895%
2/7/2024Vivo Capital LLC3,521,291$3.94M0.3%-9.0%9.274%
11/14/2023Newtyn Management LLC1,020,000$1.06M0.3%+2.0%2.688%
7/26/2023Privium Fund Management B.V.116,516$148K0.0%N/A0.308%
7/25/2023Assenagon Asset Management S.A.158,289$203K0.0%-29.9%0.419%
5/8/2023Bailard Inc.28,500$40K0.0%N/A0.075%
2/15/2023Tang Capital Management LLC400,000$520K0.1%+100.0%1.062%
2/14/2023Susquehanna International Group LLP20,307$26K0.0%N/A0.054%
2/8/2023Russell Investments Group Ltd.40,195$52K0.0%-38.2%0.107%
1/12/2023Assenagon Asset Management S.A.225,816$294K0.0%-19.3%0.600%
1/12/2023Marquette Asset Management LLC97,835$127K0.0%+53.4%0.260%
11/15/2022Caas Capital Management LP116,777$173K0.0%N/A0.310%
11/14/2022RA Capital Management L.P.533,432$789K0.0%+18.5%1.417%
11/14/2022Ergoteles LLC88,174$130K0.0%-16.5%0.234%
11/4/2022Russell Investments Group Ltd.64,995$96K0.0%-32.4%0.173%
11/1/2022Privium Fund Management UK Ltd116,516$172K0.2%N/A0.310%
10/18/2022Bailard Inc.46,383$69K0.0%N/A0.123%
Before you buy SpaceX shares, consider this alternative approach (Ad)

SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered.tc pixel

Discover the overlooked SpaceX IPO strategy before the June listing
7/29/2022Russell Investments Group Ltd.96,100$196K0.0%N/A0.256%
7/27/2022Assenagon Asset Management S.A.275,552$562K0.0%N/A0.735%
7/15/2022Marquette Asset Management LLC63,779$130K0.0%N/A0.170%
5/16/2022Echo Street Capital Management LLC123,804$5.49M0.0%N/A0.330%
5/11/2022GSA Capital Partners LLP54,038$148K0.0%N/A0.144%
5/9/2022Qube Research & Technologies Ltd19,611$54K0.0%-57.0%0.052%
2/19/2022Woodline Partners LP403,357$1.98M0.0%+2.3%1.082%
2/14/2022Suvretta Capital Management LLC2,230,250$10.93M0.2%+68.3%5.982%
2/11/2022Ensign Peak Advisors Inc18,500$91K0.0%-36.0%0.050%
2/10/2022Qube Research & Technologies Ltd45,640$224K0.0%+204.2%0.122%
2/8/2022Northern Trust Corp194,893$955K0.0%+4.3%0.523%


BOLT Institutional Ownership - Frequently Asked Questions

During the previous two years, 18 institutional investors and hedge funds held shares of Bolt Biotherapeutics. The most heavily invested institutionals were Sofinnova Investments Inc. ($795K), Acuitas Investments LLC ($473K), Vivo Capital LLC ($396K), Nan Fung Group Holdings Ltd ($337K), Renaissance Technologies LLC ($312K), T3 Companies LLC ($208K), and Board of Trustees of The Leland Stanford Junior University ($208K).Learn more on Bolt Biotherapeutics' institutional investors.

86.70% of Bolt Biotherapeutics' stock is owned by institutional investors. Learn more on BOLT's institutional investor holdings.

Of the 12 institutional investors that purchased Bolt Biotherapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Acuitas Investments LLC ($112.56K), Citadel Advisors LLC ($78.96K), Squarepoint Ops LLC ($51.42K), Velan Capital Investment Management LP ($50K), Renaissance Technologies LLC ($48.60K), Millennium Management LLC ($47.03K), and T3 Companies LLC ($38K).

Institutional investors have bought a total of 142,148 shares in the last 24 months. This purchase volume represents approximately $740.55K in transactions.

The following institutional investors have sold Bolt Biotherapeutics stock in the last 24 months: Vivo Capital LLC ($3.45M), Sofinnova Investments Inc. ($2.62M), Nan Fung Group Holdings Ltd ($1.11M), Board of Trustees of The Leland Stanford Junior University ($683.57K), Pfizer Inc ($594.80K), and Geode Capital Management LLC ($356.58K).

Institutional investors have sold a total of 8,809,150 shares in the last 24 months. This volume of shares sold represents approximately $50.80M in transactions.


Related Companies

This page (NASDAQ:BOLT) was last updated on 5/29/2026 by MarketBeat.com Staff.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel